DTB select: European Medicines Agency advice on renin-angiotensin system medicines during covid-19 pandemic

Summary and context is provided on statement from the Agency that it is not aware of any evidence from clinical or epidemiological studies that has established a link between ACEI and AIIRA medicines and worsening of covid-19; patients should not stop taking these medicines.


Drug and Therapeutics Bulletin